Home > News > Chicago's future as a tech center in jeopardy
August 7th, 2009
Chicago's future as a tech center in jeopardy
Parlaying local knowledge into the next big thing becomes tougher given the increasing complexity of today's scientific ventures, said Arthur, who explores the subject in a new book, "The Nature of Technology." Developing nanotechnology, for instance, requires collective willpower, industrial might and plenty of cash, as well as native expertise.
By many measures, Chicago has a long way to go.
Fragmented as ever, Chicago has plenty of bets, from nanotechnology and clean energy to biotech and material science. "We have some extraordinary assets," O'Connor said. "They haven't coalesced."
News and information
Arrowhead Presents Phase 1 Data on ARC-520 at HepDART 2013 December 9th, 2013
Electrical control of single atom magnets December 9th, 2013
Recycled Plastic Proves Effective in Killing Drug-Resistant Fungi: IBN and IBM discover new medical application for converted PET bottles December 9th, 2013
Oregon scientists offer new insights on controlling nanoparticle stability: New findings could enhance stabilizing or destabilizing nanoparticles, depending on their uses December 9th, 2013
Cutting Away at the NRC's Research Capability December 6th, 2013
Project aims to mass-produce 'nanopetals' for sensors, batteries October 22nd, 2013
Governor Cuomo Announces 'Nano Utica' $1.5 Billion Public-Private Investment That Will Make the Mohawk Valley New York's Next Major Hub of Nanotech Research October 12th, 2013
SUNY CNSE to Develop Marcy Nanocenter Site for 450mm Computer Chip Manufacturing: Building on Governor Cuomo’s CNSE G450C initiative and expanded partnership between NanoCollege and the Mohawk Valley EDGE continues New York’s investment strategy September 12th, 2013
Harris & Harris Group Notes ABSMaterials' Series B Financing November 22nd, 2013
Harris & Harris Group Letter to Shareholders on Website November 18th, 2013
Harris & Harris Group Reports Financial Statements as of September 30, 2013 November 12th, 2013
Harris & Harris Group Notes CordenPharma's Acquisition of Ancora's Carbohydrate Synthesis Platform and Corporate Name November 7th, 2013